# Molecular Network Analysis and Effector Gene Prioritization of Endurance-Training-Influenced Modulation of Cardiac Aging

**Authors:** Mingrui Wang, Samuhaer Azhati, Hangyu Chen, Yanyan Zhang, Lijun Shi

PMC · DOI: 10.3390/genes16070814 · Genes · 2025-07-11

## TL;DR

This study identifies key genes and pathways that link cardiac aging with the benefits of endurance training, offering potential targets for therapies to reverse age-related heart decline.

## Contribution

The study introduces a systems biology approach to prioritize effector genes that bridge cardiac aging and exercise-induced rejuvenation.

## Key findings

- Aging-related genes were linked to mitochondrial dysfunction and sarcomere disassembly.
- Exercise-responsive genes were associated with protein synthesis and lipid metabolism.
- SMPX was identified as a top gene involved in mechano-metabolic coupling and redox balance.

## Abstract

Background/Objectives: Cardiac aging involves the progressive structural and functional decline of the myocardium. Endurance training is a well-recognized non-pharmacological intervention that counteracts this decline, yet the molecular mechanisms driving exercise-induced cardiac rejuvenation remain inadequately elucidated. This study aimed to identify key effector genes and regulatory pathways by integrating human cardiac aging transcriptomic data with multi-omic exercise response datasets. Methods: A systems biology framework was developed to integrate age-downregulated genes (n = 243) from the GTEx human heart dataset and endurance-exercise-responsive genes (n = 634) from the MoTrPAC mouse dataset. Thirty-seven overlapping genes were identified and subjected to Enrichr for pathway enrichment, KEA3 for kinase analysis, and ChEA3 for transcription factor prediction. Candidate effector genes were ranked using ToppGene and ToppNet, with integrated prioritization via the FLAMES linear scoring algorithm. Results: Pathway enrichment revealed complementary patterns: aging-associated genes were enriched in mitochondrial dysfunction and sarcomere disassembly, while exercise-responsive genes were linked to protein synthesis and lipid metabolism. TTN, PDK family kinases, and EGFR emerged as major upstream regulators. NKX2-5, MYOG, and YBX3 were identified as shared transcription factors. SMPX ranked highest in integrated scoring, showing both functional relevance and network centrality, implying a pivotal role in mechano-metabolic coupling and cardiac stress adaptation. Conclusions: By integrating cardiac aging and exercise-responsive transcriptomes, 37 effector genes were identified as molecular bridges between aging decline and exercise-induced rejuvenation. Aging involved mitochondrial and sarcomeric deterioration, while exercise promoted metabolic and structural remodeling. SMPX ranked highest for its roles in mechano-metabolic coupling and redox balance, with X-inactivation escape suggesting sex-specific relevance. Other top genes (e.g., KLHL31, MYPN, RYR2) form a regulatory network supporting exercise-mediated cardiac protection, offering targets for future validation and therapy.

## Linked entities

- **Genes:** TTN (titin) [NCBI Gene 7273], Pdk (Pyruvate dehydrogenase kinase) [NCBI Gene 35970], EGFR (epidermal growth factor receptor) [NCBI Gene 1956], NKX2-5 (NK2 homeobox 5) [NCBI Gene 1482], MYOG (myogenin) [NCBI Gene 4656], YBX3 (Y-box binding protein 3) [NCBI Gene 8531], SMPX (small muscle protein X-linked) [NCBI Gene 23676], KLHL31 (kelch like family member 31) [NCBI Gene 401265], MYPN (myopalladin) [NCBI Gene 84665], RYR2 (ryanodine receptor 2) [NCBI Gene 6262]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** YBX3 (Y-box binding protein 3) [NCBI Gene 8531] {aka CSDA, CSDA1, DBPA, ZONAB}, KLHL31 (kelch like family member 31) [NCBI Gene 401265] {aka BKLHD6, KBTBD1, KLHL, bA345L23.2}, MYPN (myopalladin) [NCBI Gene 84665] {aka CMD1DD, CMH22, CMYO24, CMYP24, MYOP, NEM11}, TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, RYR2 (ryanodine receptor 2) [NCBI Gene 6262] {aka ARVC2, ARVD2, RYR-2, RyR, VACRDS, VTSIP}, NKX2-5 (NK2 homeobox 5) [NCBI Gene 1482] {aka CHNG5, CSX, CSX1, HLHS2, NKX2.5, NKX2E}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, MYOG (myogenin) [NCBI Gene 4656] {aka MYF4, bHLHc3, myf-4}, SMPX (small muscle protein X-linked) [NCBI Gene 23676] {aka Chisel, Csl, DFN6, DFNX4, MPD7}
- **Diseases:** mitochondrial dysfunction (MESH:D028361), cardiac protection (MESH:D006331)
- **Chemicals:** lipid (MESH:D008055)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12294711/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12294711/full.md

## References

167 references — full list in the complete paper: https://tomesphere.com/paper/PMC12294711/full.md

---
Source: https://tomesphere.com/paper/PMC12294711